The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Medvedev V.E.

Russian Peoples Friendship University, Moscow

Tereshchenko O.N.

Laboratoriia patofiziologii FGBU "Nauchnyĭ tsentr psikhicheskogo zdorov'ia" RAMN, Moskva

Israelian A.Iu.

Kafedra psikhiatrii, psikhoterapii i psikhosomaticheskoĭ patologii FPKMR "Rossiĭskiĭ universitet druzhby narodov", Moskva

Chobanu I.K.

Kafedra psikhiatrii, psikhoterapii i psikhosomaticheskoĭ patologii FPKMR "Rossiĭskiĭ universitet druzhby narodov", Moskva

Kost N.V.

Laboratoriia patofiziologii FGBU "Nauchnyĭ tsentr psikhicheskogo zdorov'ia" RAMN, Moskva

Sokolov O.Iu.

Laboratoriia patofiziologii FGBU "Nauchnyĭ tsentr psikhicheskogo zdorov'ia" RAMN, Moskva

Miasoedov N.F.

Laboratoriia patofiziologii FGBU "Nauchnyĭ tsentr psikhicheskogo zdorov'ia" RAMN, Moskva;
FGBUN "Institut molekuliarnoĭ genetiki" RAN, Moskva

A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders

Authors:

Medvedev V.E., Tereshchenko O.N., Israelian A.Iu., Chobanu I.K., Kost N.V., Sokolov O.Iu., Miasoedov N.F.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2014;114(7): 17‑22

Views: 2245

Downloaded: 37

Download PDF (RU)
Contact the author
Table of contents

A COMPARISON OF THE ANXIOLYTIC EFFECT AND TOLERABILITY OF SELANK AND PHENAZEPAM IN THE TREATMENT OF ANXIETY DISORDERS
A COMPARISON OF THE ANXIOLYTIC EFFECT AND TOLERABILITY OF SELANK AND PHENAZEPAM IN THE TREATMENT OF ANXIETY DISORDERS

To cite this article:

Medvedev VE, Tereshchenko ON, Israelian AIu, Chobanu IK, Kost NV, Sokolov OIu, Miasoedov NF. A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2014;114(7):17‑22. (In Russ.)

Подписка 2025-2 (S.S. Korsakov Journal of Neurology and Psychiatry)
 
МСФ на ЯМ
Close metadata
Recommended articles:
Fluvoxamine in the treatment of anxiety-depressive spectrum diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):101-109
Anxiety diso­rders as como­rbid conditions in neuropsychiatric diseases in children. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):56-64
Deve­lopment of a diagnostic and treatment algo­rithm for anxiety asso­ciated with soma­tic pathology in patients in gene­ral clinical practice. Reso­lution of the expert council. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):62-69

Objective. To study the efficacy and tolerability of the new anxyolytic peptide selank in comparison with phenazepam. Material and methods. A comparative study of the anxiolytic effect and tolerability of selank and phenazepam was carried out in 60 patients with phobic-anxiety- and somatoform disorders (F40.2-9, F41.1-9, F45.0-1 by ICD-10) were examined. Results Pronounced anxiolytic and mild nootropic effects of selank were demonstrated. The anxiolytic effect lasted for a week after last receiving the peptide. Selank had a positive impact on the quality of life of the patients. Conclusion. The data obtained in the study extend therapeutic possibilities in the treatment of anxiety disorders.

Keywords:

anxiety disorders
anxiolytic effect
selank
phenazepam

Authors:

Medvedev V.E.

Russian Peoples Friendship University, Moscow

Tereshchenko O.N.

Laboratoriia patofiziologii FGBU "Nauchnyĭ tsentr psikhicheskogo zdorov'ia" RAMN, Moskva

Israelian A.Iu.

Kafedra psikhiatrii, psikhoterapii i psikhosomaticheskoĭ patologii FPKMR "Rossiĭskiĭ universitet druzhby narodov", Moskva

Chobanu I.K.

Kafedra psikhiatrii, psikhoterapii i psikhosomaticheskoĭ patologii FPKMR "Rossiĭskiĭ universitet druzhby narodov", Moskva

Kost N.V.

Laboratoriia patofiziologii FGBU "Nauchnyĭ tsentr psikhicheskogo zdorov'ia" RAMN, Moskva

Sokolov O.Iu.

Laboratoriia patofiziologii FGBU "Nauchnyĭ tsentr psikhicheskogo zdorov'ia" RAMN, Moskva

Miasoedov N.F.

Laboratoriia patofiziologii FGBU "Nauchnyĭ tsentr psikhicheskogo zdorov'ia" RAMN, Moskva;
FGBUN "Institut molekuliarnoĭ genetiki" RAN, Moskva

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.